학술논문

TMEM106B regulates microglial proliferation and survival in response to demyelination
Document Type
article
Source
Science Advances. 9(18)
Subject
Biochemistry and Cell Biology
Biomedical and Clinical Sciences
Biological Sciences
Neurodegenerative
Brain Disorders
Neurosciences
2.1 Biological and endogenous factors
Aetiology
Neurological
Humans
Mice
Animals
Microglia
Mice
Knockout
Brain
Demyelinating Diseases
Cell Proliferation
Membrane Proteins
Nerve Tissue Proteins
Membrane Glycoproteins
Receptors
Immunologic
Language
Abstract
TMEM106B, a lysosomal transmembrane protein, has been closely associated with brain health. Recently, an intriguing link between TMEM106B and brain inflammation has been discovered, but how TMEM106B regulates inflammation is unknown. Here, we report that TMEM106B deficiency in mice leads to reduced microglia proliferation and activation and increased microglial apoptosis in response to demyelination. We also found an increase in lysosomal pH and a decrease in lysosomal enzyme activities in TMEM106B-deficient microglia. Furthermore, TMEM106B loss results in a significant decrease in the protein levels of TREM2, an innate immune receptor essential for microglia survival and activation. Specific ablation of TMEM106B in microglia results in similar microglial phenotypes and myelination defects in mice, supporting the idea that microglial TMEM106B is critical for proper microglial activities and myelination. Moreover, the TMEM106B risk allele is associated with myelin loss and decreased microglial numbers in humans. Collectively, our study unveils a previously unknown role of TMEM106B in promoting microglial functionality during demyelination.